News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

NeuroDigm's Model Reveals the Reversal of Chronic Pain


2/4/2008 9:22:03 AM

FT. WORTH, Texas--(BUSINESS WIRE)--Mary Hannaman MD, president of NeuroDigm Co. in Fort Worth, Texas has confirmed that a recombinant human erythropoietin, epoetin alfa, can reverse neural changes that cause chronic pain behavior. Using their Biogenic Model of Chronic Pain™, epoetin alpha was applied once locally in micro doses to the affected nerves resulting in the reversal of pain behaviors permanently.

Read at BioSpace.com


comments powered by Disqus
NeuroDigm
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES